We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the
AML is a curable disease, but the prognosis varies greatly, depending primarily on the age and health status of the patient, the subtype of AML, and the treatment response.
Among other factors, advanced age, the presence of certain genetic/molecular abnormalities, initial leukocyte count, and AML related to prior treatments or secondary to other previous haematological diseases are some of the parameters involved in an unfavourable prognosis.
Different factors can affect the prognosis of the disease
The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.
Receive the latest updates related to this content.
Thank you for subscribing!
If this is the first time you subscribe you will receive a confirmation email, check your inbox
An error occurred and we were unable to send your data, please try again later.